Γκίγκο (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Γκίγκο" in Greek language version.

refsWebsite

Global rank Greek rank

22nih.gov

4^th place

18doi.org

2^nd place

3^rd place

3archive.org

6^th place

5^th place

1bbc.co.uk

8^th place

20^th place

1globalplantcouncil.org

low place

1eurekalert.org

3,538^th place

2,508^th place

1drugs.com

399^th place

130^th place

archive.org

«Ginkgo Seed Poisoning». PEDIATRICS 109 (2): 325-327. Φεβρουάριος 2002. https://archive.org/details/sim_pediatrics_2002-02_109_2/page/325.
Lepoittevin, J.-P.; Benezra, C.; Asakawa, Y. (1989). «Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol». Archives of Dermatological Research 281 (4): 227–30. doi:10.1007/BF00431055. PMID 2774654. https://archive.org/details/sim_archives-of-dermatological-research_1989-07_281_4/page/227.
Jiang X; Williams KM; Liauw WS; Ammit AJ και άλλοι. (Απρίλιος 2005). «Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects». Br J Clin Pharmacol 59 (4): 425–32. doi:10.1111/j.1365-2125.2005.02322.x. PMID 15801937. PMC 1884814. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2005-04_59_4/page/425.

bbc.co.uk

«Ginkgo 'living fossil' genome decoded» (στα αγγλικά). BBC News. 2016-11-21. http://www.bbc.co.uk/news/science-environment-38057741. Ανακτήθηκε στις 2016-11-22.

doi.org

dx.doi.org

Laws KR; Sweetnam H; Kondel TK (Νοέμβριος 2012). «Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis». Human Psychopharmacology 27 (6): 527-33. doi:10.1002/hup.2259. PMID 23001963.
Birks, J; Grimley Evans, J (2009-01-21). «Ginkgo biloba for cognitive impairment and dementia». The Cochrane database of systematic reviews (1): CD003120. doi:10.1002/14651858.CD003120.pub3. PMID 19160216.
Cooper, C; Li, R; Lyketsos, C; Livingston, G (Σεπτέμβριος 2013). «Treatment for mild cognitive impairment: systematic review». The British Journal of Psychiatry 203 (3): 255–64. doi:10.1192/bjp.bp.113.127811. PMID 24085737.
Mancuso, C; Siciliano, R; Barone, E; Preziosi, P (Μάιος 2012). «Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine». Biochimica et Biophysica Acta 1822 (5): 616–24. doi:10.1016/j.bbadis.2011.09.004. PMID 21939756.
Weinmann, S; Roll, S; Schwarzbach, C; Vauth, C; Willich, SN (2010). «Effects of Ginkgo biloba in dementia: systematic review and meta-analysis». BMC geriatrics 10 (14). doi:10.1186/1471-2318-10-14. PMID 20236541.
Tan, MS; Yu, JT; Tan, CC; Wang, HF και άλλοι. (2014-08-11). «Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis». Journal of Alzheimer's disease: JAD (43): 589–603. doi:10.3233/JAD-140837. PMID 25114079.
Meng-Shan Tan; Jin-Tai Yu; Chen-Chen Tan; Hui-Fu Wang και άλλοι. (2015). «Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis». Journal of Alzheimer's Disease 43 (2): 589–603. doi:10.3233/JAD-140837. PMID 25114079.
Xiong XJ; Liu W; Yang XC; Feng B και άλλοι. (Σεπτέμβριος 2014). «Ginkgo biloba extract for essential hypertension: A systemic review». Phytomedicine 21 (10): 1131-6. doi:10.1016/j.phymed.2014.04.024.
Clement, YN; Onakpoya, I; Hung, SK; Ernst, E (Μάρτιος 2011). «Effects of herbal and dietary supplements on cognition in menopause: a systematic review». Maturitas 68 (3): 256–63. doi:10.1016/j.maturitas.2010.12.005. PMID 21237589.
Hilton, MP; Zimmermann, EF; Hunt, WT (2013-03-28). «Ginkgo biloba for tinnitus». The Cochrane database of systematic reviews (3): CD003852. doi:10.1002/14651858.CD003852.pub3. PMID 23543524.
Zeng X; Liu M; Yang Y; Li Y; Asplund K (2005). «Ginkgo biloba for acute ischaemic stroke». Cochrane Database Syst Rev (Systematic review) (4): CD003691. doi:10.1002/14651858.CD003691.pub2. PMID 16235335.
Nicolaï SP; Kruidenier LM; Bendermacher BL; Prins M; Stokmans R; Broos P; Teijink J (Ιούνιος 2013). «Ginkgo biloba for intermittent claudication». Cochrane Database Syst Rev. (6): CD006888. doi:10.1002/14651858.CD006888.pub3. PMID 23744597.
Evans, JR (2013-01-31). «Ginkgo biloba extract for age-related macular degeneration». The Cochrane database of systematic reviews (1): CD001775. doi:10.1002/14651858.CD001775.pub2. PMID 23440785.
Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS (2004-04-03). «Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)». BMJ 328 (7443): 797. doi:10.1136/bmj.38043.501690.7C. PMID 15070635.
Seupaul, RA; Welch, JL; Malka, ST; Emmett, TW (Απρίλιος 2012). «Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review». Annals of Emergency Medicine 59 (4): 307–317.e1.. doi:10.1016/j.annemergmed.2011.10.015. PMID 22153998.
Lepoittevin, J.-P.; Benezra, C.; Asakawa, Y. (1989). «Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol». Archives of Dermatological Research 281 (4): 227–30. doi:10.1007/BF00431055. PMID 2774654. https://archive.org/details/sim_archives-of-dermatological-research_1989-07_281_4/page/227.
Schötz, Karl (2004). «Quantiﬁcation of allergenic urushiols in extracts ofGinkgo biloba leaves, in simple one-step extracts and reﬁned manufactured material(EGb 761)». Phytochemical Analysis 15 (1): 1–8. doi:10.1002/pca.733. PMID 14979519.
Jiang X; Williams KM; Liauw WS; Ammit AJ και άλλοι. (Απρίλιος 2005). «Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects». Br J Clin Pharmacol 59 (4): 425–32. doi:10.1111/j.1365-2125.2005.02322.x. PMID 15801937. PMC 1884814. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2005-04_59_4/page/425.

drugs.com

http://www.drugs.com/npp/ginkgo.html

eurekalert.org

«Living fossil genome unveiled». EurekAlert!. Ανακτήθηκε στις 22 Νοεμβρίου 2016.

globalplantcouncil.org

House, Graphical. «Living Fossil Genome Unveiled». globalplantcouncil.org. Ανακτήθηκε στις 22 Νοεμβρίου 2016. ^{[νεκρός σύνδεσμος]}

nih.gov

ncbi.nlm.nih.gov

Laws KR; Sweetnam H; Kondel TK (Νοέμβριος 2012). «Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis». Human Psychopharmacology 27 (6): 527-33. doi:10.1002/hup.2259. PMID 23001963.
Birks, J; Grimley Evans, J (2009-01-21). «Ginkgo biloba for cognitive impairment and dementia». The Cochrane database of systematic reviews (1): CD003120. doi:10.1002/14651858.CD003120.pub3. PMID 19160216.
Cooper, C; Li, R; Lyketsos, C; Livingston, G (Σεπτέμβριος 2013). «Treatment for mild cognitive impairment: systematic review». The British Journal of Psychiatry 203 (3): 255–64. doi:10.1192/bjp.bp.113.127811. PMID 24085737.
Mancuso, C; Siciliano, R; Barone, E; Preziosi, P (Μάιος 2012). «Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine». Biochimica et Biophysica Acta 1822 (5): 616–24. doi:10.1016/j.bbadis.2011.09.004. PMID 21939756.
Weinmann, S; Roll, S; Schwarzbach, C; Vauth, C; Willich, SN (2010). «Effects of Ginkgo biloba in dementia: systematic review and meta-analysis». BMC geriatrics 10 (14). doi:10.1186/1471-2318-10-14. PMID 20236541.
Tan, MS; Yu, JT; Tan, CC; Wang, HF και άλλοι. (2014-08-11). «Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis». Journal of Alzheimer's disease: JAD (43): 589–603. doi:10.3233/JAD-140837. PMID 25114079.
Meng-Shan Tan; Jin-Tai Yu; Chen-Chen Tan; Hui-Fu Wang και άλλοι. (2015). «Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis». Journal of Alzheimer's Disease 43 (2): 589–603. doi:10.3233/JAD-140837. PMID 25114079.
Clement, YN; Onakpoya, I; Hung, SK; Ernst, E (Μάρτιος 2011). «Effects of herbal and dietary supplements on cognition in menopause: a systematic review». Maturitas 68 (3): 256–63. doi:10.1016/j.maturitas.2010.12.005. PMID 21237589.
Hilton, MP; Zimmermann, EF; Hunt, WT (2013-03-28). «Ginkgo biloba for tinnitus». The Cochrane database of systematic reviews (3): CD003852. doi:10.1002/14651858.CD003852.pub3. PMID 23543524.
Zeng X; Liu M; Yang Y; Li Y; Asplund K (2005). «Ginkgo biloba for acute ischaemic stroke». Cochrane Database Syst Rev (Systematic review) (4): CD003691. doi:10.1002/14651858.CD003691.pub2. PMID 16235335.
Nicolaï SP; Kruidenier LM; Bendermacher BL; Prins M; Stokmans R; Broos P; Teijink J (Ιούνιος 2013). «Ginkgo biloba for intermittent claudication». Cochrane Database Syst Rev. (6): CD006888. doi:10.1002/14651858.CD006888.pub3. PMID 23744597.
Evans, JR (2013-01-31). «Ginkgo biloba extract for age-related macular degeneration». The Cochrane database of systematic reviews (1): CD001775. doi:10.1002/14651858.CD001775.pub2. PMID 23440785.
Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS (2004-04-03). «Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)». BMJ 328 (7443): 797. doi:10.1136/bmj.38043.501690.7C. PMID 15070635.
Seupaul, RA; Welch, JL; Malka, ST; Emmett, TW (Απρίλιος 2012). «Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review». Annals of Emergency Medicine 59 (4): 307–317.e1.. doi:10.1016/j.annemergmed.2011.10.015. PMID 22153998.
Lepoittevin, J.-P.; Benezra, C.; Asakawa, Y. (1989). «Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol». Archives of Dermatological Research 281 (4): 227–30. doi:10.1007/BF00431055. PMID 2774654. https://archive.org/details/sim_archives-of-dermatological-research_1989-07_281_4/page/227.
Schötz, Karl (2004). «Quantiﬁcation of allergenic urushiols in extracts ofGinkgo biloba leaves, in simple one-step extracts and reﬁned manufactured material(EGb 761)». Phytochemical Analysis 15 (1): 1–8. doi:10.1002/pca.733. PMID 14979519.
Jiang X; Williams KM; Liauw WS; Ammit AJ και άλλοι. (Απρίλιος 2005). «Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects». Br J Clin Pharmacol 59 (4): 425–32. doi:10.1111/j.1365-2125.2005.02322.x. PMID 15801937. PMC 1884814. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2005-04_59_4/page/425.

pubmedcentral.nih.gov

Cooper, C; Li, R; Lyketsos, C; Livingston, G (Σεπτέμβριος 2013). «Treatment for mild cognitive impairment: systematic review». The British Journal of Psychiatry 203 (3): 255–64. doi:10.1192/bjp.bp.113.127811. PMID 24085737.
Weinmann, S; Roll, S; Schwarzbach, C; Vauth, C; Willich, SN (2010). «Effects of Ginkgo biloba in dementia: systematic review and meta-analysis». BMC geriatrics 10 (14). doi:10.1186/1471-2318-10-14. PMID 20236541.
Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS (2004-04-03). «Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)». BMJ 328 (7443): 797. doi:10.1136/bmj.38043.501690.7C. PMID 15070635.
Jiang X; Williams KM; Liauw WS; Ammit AJ και άλλοι. (Απρίλιος 2005). «Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects». Br J Clin Pharmacol 59 (4): 425–32. doi:10.1111/j.1365-2125.2005.02322.x. PMID 15801937. PMC 1884814. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2005-04_59_4/page/425.

nccih.nih.gov

«Ginkgo». National Center for Complementary and Integrative Health. US National Institutes of Health. 2014. Ανακτήθηκε στις 19 Φεβρουαρίου 2022.